AZN

AstraZeneca
AZN

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£170.36B
EV
£190.80B
Shares Outstanding
1.55B
Beta
0.17

Wall Street View

Analyst Rating
BUY
Analyst Target Price
£179.12
P/E 2025E
16.57x
P/Revenue 2025E
4.00x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About AstraZeneca PLC

gainify
AZN

AstraZeneca PLC

AZN

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company’s marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslo...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Soriot, Pascal

Employees

94,300

IPO Date

1993-05-21

Headquarters

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, Cambridgeshire, CB2 0AA, United Kingdom

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.